1. An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
   Qingmei Ye et al, 2023, Frontiers in Pharmacology CrossRef
2. Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment
   Li-Juan Deng et al, 2020, European Journal of Pharmacology CrossRef
3. Effects of low‑dose bufalin combined with hydroxycamptothecin on human castration‑resistant prostate cancer xenografts in nude mice
   Renze Gu et al, 2021, Experimental and Therapeutic Medicine CrossRef
4. Advances in the treatment of pancreatic cancer with traditional Chinese medicine
   Yanhua Zhang et al, 2023, Frontiers in Pharmacology CrossRef
5. Evaluating the Cancer Therapeutic Potential of Cardiac Glycosides
   José Manuel Calderón-Montaño et al, 2014, BioMed Research International CrossRef
6. Targeting Na+/K+‐translocating adenosine triphosphatase in cancer treatment
   Cameron T. Durlacher et al, 2015, Clinical and Experimental Pharmacology and Physiology CrossRef
7. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway
   Xia Liu et al, 2016, Journal of Ethnopharmacology CrossRef
8. Venenum bufonis: An overview of its traditional use, natural product chemistry, pharmacology, pharmacokinetics and toxicology
   Wen-Long Wei et al, 2019, Journal of Ethnopharmacology CrossRef
9. Emergence of Cardiac Glycosides as Potential Drugs: Current and Future Scope for Cancer Therapeutics
   Ranjith Kumavath et al, 2021, Biomolecules CrossRef
10. Bufalin inhibits the differentiation and proliferation of human osteosarcoma cell line hMG63-derived cancer stem cells
    Yuewen Chang et al, 2014, Tumor Biology CrossRef
11. Use of herbal medicines and natural products: An alternative approach to overcoming the apoptotic resistance of pancreatic cancer
    Lin Li et al, 2014, The International Journal of Biochemistry & Cell Biology CrossRef
12. New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
    Chien-shan Cheng et al, 2019, Cancer Cell International CrossRef
13. Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway
    Fei Liu et al, 2016, Oncotarget CrossRef
14. The Effect of Bufalin Combined with Ciplatin on Apoptosis of Osteosarcoma 143B Cells
    林 贾, 2020, Advances in Clinical Medicine CrossRef
15. Bufalin for an innovative therapeutic approach against cancer
    Laura Soumoy et al, 2022, Pharmacological Research CrossRef
16. Global trends in bufalin application research for cancer from 2003 to 2022: A bibliometric and visualised analysis
    Donghao Tang et al, 2024, Heliyon CrossRef